This section of Janssen's global website offers an overview of the company in several languages. It is not intended for a specific audience or country. Click here for country and region specific information of interest. Status of the Janssen vaccine for COVID-19> MENU VISIT JANSSEN GLOBAL CHANGE LOCATION> ITALIAN CHANGE LANGUAGE> Company update The U.S. CDC Advisory Committee unanimously recommends J&J COVID-19 vaccine as a booster for all eligible individuals receiving licensed COVID-19 vaccines Read all the news > We never stop working to create a future where disease is a thing of the past. Trova lavoro in Janssen > Centro informazioni > Contattaci > Chi siamo Crediamo che affrontare le difficoltà sia il modo migliore per risolverle. Ecco perché, in oltre 150 paesi, riuniamo le menti più creative e la tecnologia all'avanguardia per aiutare a trattare, curare, arrestare e prevenire alcune delle malattie più complesse dei nostri tempi. ULTERIORI INFORMAZIONI Fare la differenza Ogni giorno, i nostri farmaci aiutano milioni di persone. Il nostro impegno a fornire al mondo innovazioni rivoluzionarie è continuo. Queste sono solo alcune delle storie su come Janssen sta facendo la differenza in ogni angolo del mondo. VISUALIZZA STORIE Backed by the scale and reach of Johnson & Johnson, we are transforming life and reinventing healthcare as we address society's most pressing health challenges. Explore Janssen on Social Media Find the latest news on our social media feeds. Click below to explore and follow us. FIND JANSSEN ON: FIND JANSSEN ON: PRIVACY POLICY LEGAL NOTICES CONTACT US WORK WITH US INFORMATION CENTER janssen global © Janssen Global Services, LLC, 2012-2021. All rights reserved. The use of information on the site by users is subject to our Legal Notice . See our Privacy Policy . This site is published by Janssen Global Services, LLC which is solely responsible for its contents. Capitalized product names are trademarks of Johnson & Johnson or its affiliates. This information is intended for an international audience. Country-specific information is identified where present. All third party trademarks used herein are registered trademarks of their respective owners. Last updated: November 24, 2021